Pilot and Feasibility Studies | |
Towards an integrated blood pressure self-monitoring solution for stroke/TIA in Ireland: a mixed methods feasibility study for the TASMIN5S IRL randomised controlled trial | |
Research | |
K. Morton1  A. Sheikhi2  C. Roman3  R. J. McManus4  T. Rai4  R. Hebert5  R. Doogue5  L. G. Glynn6  P. Hayes7  | |
[1] Centre for Clinical and Community Applications of Health Psychology, School of Psychology, University of Southampton, SO17 1BJ, Southampton, UK;Health Research Institute, University of Limerick, Limerick, Ireland;Institute of Biomedical Engineering, Department of Engineering Science, University of Oxford, Oxford, UK;Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK;School of Medicine, University of Limerick, Limerick, Ireland;School of Medicine, University of Limerick, Limerick, Ireland;HRB Primary Care Clinical Trial Network Ireland, Galway, Ireland;School of Medicine, University of Limerick, Limerick, Ireland;Health Research Institute, University of Limerick, Limerick, Ireland; | |
关键词: Blood pressure; Self-monitoring; Stroke; Feasibility studies; Randomised controlled trial; Qualitative research; | |
DOI : 10.1186/s40814-023-01240-2 | |
received in 2022-01-15, accepted in 2023-01-04, 发布年份 2023 | |
来源: Springer | |
【 摘 要 】
BackgroundOptimising blood pressure (BP) control is one of the most important modifiable risk factors in preventing subsequent stroke where the risk increases by one-third for every 10 mmHg rise in systolic BP. This study evaluated the feasibility and potential effectiveness of blood pressure self-monitoring with planned medication titration, to inform a definitive trial of the intervention, in patients with a previous stroke or transient ischaemic attack (TIA).MethodsPatients with a history of stroke/TIA and sub-optimal BP control were invited to take part in a mixed methods feasibility study for a randomised controlled trial. Those meeting the inclusion criteria with systolic BP >130 mmHg were randomised to a self-monitoring intervention group or usual care group. The intervention involved self-monitoring BP twice a day for 3 days within a 7-day period, every month, following text message reminders. Treatment escalation, based on a pre-agreed plan by the general practitioner (GP) and patient, was initiated according to the results of these readings. Semi-structured interviews were carried out with patients and clinicians and analysed thematically.ResultsOf those identified, 47% (32/68) attended for assessment. Of those assessed, 15 were eligible for recruitment and were consented and randomised to the intervention or control group on a 2:1 basis. Of those randomised, 93% (14/15) completed the study and there were no adverse events. Systolic BP was lower in the intervention group at 3 months. Participants found the intervention acceptable and easy to use. GPs found it easy to incorporate into their practice activity without increasing workload.ConclusionsTASMIN5S, an integrated blood pressure self-monitoring intervention in patients with a previous stroke/TIA, is feasible and safe to deliver in primary care. A pre-agreed three-step medication titration plan was easily implemented, increased patient involvement in their care, and had no adverse effects. This feasibility study provides important information to inform a definitive trial to determine the potential effectiveness of the intervention in patients post-stroke or TIA.Trial registrationISRCTN57946500. Registered on 12/08/2019.
【 授权许可】
CC BY
© The Author(s) 2023
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
RO202305113832914ZK.pdf | 2731KB | download | |
Fig. 60 | 330KB | Image | download |
Fig. 2 | 226KB | Image | download |
40798_2022_490_Article_IEq71.gif | 1KB | Image | download |
Fig. 1 | 559KB | Image | download |
【 图 表 】
Fig. 1
40798_2022_490_Article_IEq71.gif
Fig. 2
Fig. 60
【 参考文献 】
- [1]
- [2]
- [3]
- [4]
- [5]
- [6]
- [7]
- [8]
- [9]
- [10]
- [11]
- [12]
- [13]
- [14]
- [15]
- [16]
- [17]
- [18]
- [19]
- [20]
- [21]
- [22]
- [23]
- [24]
- [25]
- [26]
- [27]
- [28]
- [29]
- [30]
- [31]
- [32]
- [33]
- [34]
- [35]
- [36]
- [37]
- [38]
- [39]
- [40]
- [41]
- [42]
- [43]